Division B — Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2026
DIVISION B Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2026
TITLE I Agricultural Programs
Processing, Research, and Marketing
Executive Operations
Office of the Chief Information Officer
Office of the Chief Financial Officer
Office of the Assistant Secretary for Civil Rights
Office of Civil Rights
Agriculture Buildings and Facilities
Hazardous Materials Management
Office of Safety, Security, and Protection
Office of Inspector General
Office of the General Counsel
Office of Ethics
Office of the Under Secretary for Research, Education, and Economics
Economic Research Service
National Agricultural Statistics Service
Agricultural Research Service
National Institute of Food and Agriculture
Office of the Under Secretary for Marketing and Regulatory Programs
Animal and Plant Health Inspection Service
Agricultural Marketing Service
Office of the Under Secretary for Food Safety
Food Safety and Inspection Service
TITLE II Farm Production and Conservation Programs
Office of the Under Secretary for Farm Production and Conservation
Farm Production and Conservation Business Center
Farm Service Agency
Risk Management Agency
Natural Resources Conservation Service
Corporations
TITLE III Rural Development Programs
Office of the Under Secretary for Rural Development
Rural Development
Rural Housing Service
Rural Business—Cooperative Service
Rural Utilities Service
TITLE IV Domestic Food Programs
Office of the Under Secretary for Food, Nutrition, and Consumer Services
Food and Nutrition Service
TITLE V Foreign Assistance and Related Programs
Office of the Under Secretary for Trade and Foreign Agricultural Affairs
Foreign Agricultural Service
TITLE VI Related Agency and Food and Drug Administration
Department of Health and Human Services
Independent Agency
TITLE VII General Provisions
Sec. 701.
Sec. 702.
Sec. 703.
Sec. 704.
Sec. 705.
Sec. 706.
Sec. 707.
Sec. 708.
Sec. 709.
Sec. 710.
Sec. 711.
Sec. 712.
Sec. 713.
Sec. 714.
Sec. 715.
Sec. 716.
unless the Secretary of Agriculture or the Secretary of Health and Human Services (as the case may be) notifies in writing and receives approval from the Committees on Appropriations of both Houses of Congress at least 30 days in advance of the reprogramming of such funds or the use of such authority.
unless the Secretary of Agriculture or the Secretary of Health and Human Services (as the case may be) notifies in writing and receives approval from the Committees on Appropriations of both Houses of Congress at least 30 days in advance of the reprogramming or transfer of such funds or the use of such authority.
unless the agencies funded by this Act notify, in writing, the Committees on Appropriations of both Houses of Congress at least 30 days in advance of using the funds for these purposes.
Sec. 717.
Sec. 718.
Sec. 719.
Sec. 720.
Sec. 721.
Sec. 722.
Sec. 723.
Sec. 724.
Sec. 725.
Sec. 726.
Sec. 727.
Sec. 728.
Sec. 729.
Sec. 730.
Sec. 731.
Sec. 732.
Sec. 733.
Sec. 734.
Sec. 735.
Sec. 736.
Sec. 737.
Sec. 738.
Sec. 739.
Sec. 740.
Sec. 741.
Sec. 742.
Sec. 743.
Sec. 744.
Sec. 745.
Sec. 746.
Sec. 747.
Sec. 748.
Sec. 749.
Sec. 750.
Sec. 751.
Sec. 752.
Sec. 753.
Sec. 754.
Sec. 755.
Sec. 756.
Sec. 757.
Sec. 758.
Sec. 759.
Sec. 760.
Sec. 761.
Sec. 762.
Sec. 763.
Sec. 764.
Sec. 765.
“(F) section 514 or 515 of the Housing Act of 1949 (42 U.S.C. 1484, 1485).”
Sec. 766.
Sec. 767.
Sec. 768.
Sec. 769.
Sec. 770.
Sec. 771.
Sec. 772.
Sec. 773.
Sec. 774.
Sec. 775.
Sec. 776.
Sec. 777.
Sec. 778.
Sec. 779.
Sec. 780.
Sec. 781.
“(1) Hemp.—
“(A) In general.—The term ‘hemp’ means the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total tetrahydrocannabinols concentration (including tetrahydrocannabinolic acid) of not more than 0.3 percent on a dry weight basis.
“(B) Inclusion.—Such term includes industrial hemp.
“(C) Exclusions.—Such term does not include—
“(i) any viable seeds from a Cannabis sativa L. plant that exceeds a total tetrahydrocannabinols concentration (including tetrahydrocannabinolic acid) of 0.3 percent in the plant on a dry weight basis; or
“(ii) any intermediate hemp-derived cannabinoid products containing—
“(I) cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant;
“(II) cannabinoids that—
“(aa) are capable of being naturally produced by a Cannabis sativa L. plant; and
“(bb) were synthesized or manufactured outside the plant; or
“(III) more than 0.3 percent combined total of—
“(aa) total tetrahydrocannabinols (including tetrahydrocannabinolic acid); and
“(bb) any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services); or
“(iii) any intermediate hemp-derived cannabinoid products which are marketed or sold as a final product or directly to an end consumer for personal or household use; or
“(iv) any final hemp-derived cannabinoid products containing—
“(I) cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant;
“(II) cannabinoids that—
“(aa) are capable of being naturally produced by a Cannabis sativa L. plant; and
“(bb) were synthesized or manufactured outside the plant; or
“(III) greater than 0.4 milligrams combined total per container of—
“(aa) total tetrahydrocannabinols (including tetrahydrocannabinolic acid); and
“(bb) any other cannabinoids that have similar effects (or are marketed to have similar effects) on humans or animals as a tetrahydrocannabinol (as determined by the Secretary of Health and Human Services).
“(2) Industrial hemp.—The term ‘industrial hemp’ means hemp—
“(A) grown for the use of the stalk of the plant, fiber produced from such a stalk, or any other non-cannabinoid derivative, mixture, preparation, or manufacture of such a stalk;
“(B) grown for the use of the whole grain, oil, cake, nut, hull, or any other non-cannabinoid compound, derivative, mixture, preparation, or manufacture of the seeds of such plant;
“(C) grown for purposes of producing microgreens or other edible hemp leaf products intended for human consumption that are derived from an immature hemp plant that is grown from seeds that do not exceed the threshold for total tetrahydrocannabinols concentration specified in paragraph (1)(C)(i);
“(D) that is a plant that does not enter the stream of commerce and is intended to support hemp research at an institution of higher education (as defined in section 101 of the Higher Education Act of 1965 (20 U.S.C. 1001)) or an independent research institute; or
“(E) grown for the use of a viable seed of the plant produced solely for the production or manufacture of any material described in subparagraphs (A) through (D).
“(3) Hemp-derived cannabinoid product.—
“(A) In general.—The term ‘hemp-derived cannabinoid product’ means any intermediate or final product derived from hemp (other than industrial hemp), that—
“(i) contains cannabinoids in any form; and
“(ii) is intended for human or animal use through any means of application or administration, such as inhalation, ingestion, or topical application.
“(B) The term ‘intermediate hemp-derived cannabinoid product’ means a hemp-derived cannabinoid product which—
“(i) is not yet in the final form or preparation marketed or intended to be used or consumed by a human or animal; or
“(ii) is a powder, liquid, tablet, oil, or other product form which is intended or marketed to be mixed, dissolved, formulated, or otherwise added to or prepared with or into any other substance prior to administration or consumption.
“(C) The term ‘container’ means the innermost wrapping, packaging, or vessel in direct contact with a final hemp-derived cannabinoid product in which the final hemp-derived cannabinoid product is enclosed for retail sale to consumers, such as a jar, bottle, bag, box, packet, can, carton, or cartridge.
“(D) The term container excludes bulk shipping containers or outer wrappings that are not essential for the final retail delivery or sale to an end consumer for personal or household use.
“(E) Exclusion.—Such term does not include a drug that is the subject of an application approved under subsection (c) or (j) of section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355).”